In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 13, Issue 2, 2001, Pages 222-228

  Murai, T ^a   Muller U ^a   Werheid, K ^a   Sorger, D ^a   Reuter, M ^a   Becker, T ^a   Yves von Cramon, D ^a   Barthel, H ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER IODINE I 123; DOPAMINE TRANSPORTER; IODINE 123; SEROTONIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CEREBELLUM CORTEX; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; IN VIVO STUDY; MALE; NEUROPSYCHIATRY; NEUROTRANSMITTER RELEASE; PARKINSON DISEASE; PRIORITY JOURNAL; RATING SCALE; SEROTONINERGIC NERVE CELL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATE CORTEX; STRIATONIGRAL DEGENERATION; THALAMUS;

EID: 0034981171     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.13.2.222     Document Type: Article

References (30)

1. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
2. Post mortem studies in Parkinson's disease: Is it possible to detect brain areas for specific symptoms?
3. Altered serotonin metabolism in depressed patients with Parkinson's disease
4. Clinical and biochemical features of depression in Parkinson's disease
5. 123I]-β-Carbomethoxy-3-β-(4-iodophenyl)-tropane (β-CIT): High affinity SPECT radiotracer of monoamine reuptake sites in brain
6. 11C]β-CIT binding to monoamine transporters in the monkey and human brain
7. Imaging of serotonin and dopamine transporters in the living human brain
8. SPECT imaging demonstrates loss of striatal transporters in Parkinson's disease
9. 123I]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease
10. Imaging of dopamine transporters with iodine-123-β-CIT and SPECT in Parkinson's disease
11. Clinical manifestation of Parkinson's disease
12. Unified Parkinson's disease rating scale
13. Simplified multidose preparation of iodine-123-beta-CIT: A marker for dopamine transporters
14. Striatal uptake of I-123-β-CIT and I-123-IBZM in patients with extrapyramidal symptoms
15. Brain perfusion SPECT using an annular single crystal camera: Initial clinical experience
16. 123I]β-CIT binding to dopamine transporters in healthy subjects
17. 123I]β-CIT: Pharmacological characterization of brain uptake in nonhuman primates
18. SPECT measurement of iodine-123-β-CIT binding to dopamine and serotonin transporters in Parkinson's disease: Correlation with symptom severity
19. A comparative study on neurochemistry of cerebrospinal fluid in advanced Parkinson's disease
20. 123I] β-CIT: Binding kinetics in the human brain
21. 123I-β-CIT SPECT: Binding kinetics and effects of normal aging
22. Verbesserung der diagnostik bei morbus Parkinson durch multimodale bilddatenanalyse?
23. Serotonergic dysfunction in depression associated with Parkinson's disease
24. Parkinson's disease and depression: Evidence for an alteration of the basal limbic system detected by transcranial sonography
25. 2 serotonin receptors and cognitive performance following stroke
26. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users
27. Memory impairment in abstinent MDMA ("ecstasy") users
28. 123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography
29. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour
30. 2 receptor occupancy by endogenous dopamine in healthy humans